Category Archives: Progestogens

Denmark population-wide study confirms association between cyproterone acetate and meningioma risk – and recent users of CPA are disproportionately trans women

Previously: Additional data confirms 10mg of cyproterone acetate (CPA) is effective for testosterone suppression in trans women (June 2021) Disclaimer: I am not a medical professional and this is not medical advice. Since 2018, I’ve been covering emerging findings on … Continue reading

Posted in Antiandrogens, Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine | Tagged , , , | Leave a comment

Additional data confirms 10mg of cyproterone acetate (CPA) is effective for testosterone suppression in trans women

Previously: Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects (August 2020) Study of entire French population offers further data on cyproterone acetate and meningioma risk (February 2021) Disclaimer: I … Continue reading

Posted in Antiandrogens, Endocrinology, Oncology, Progestogens, Transgender medicine | Tagged , , | Leave a comment

Study of entire French population offers further data on cyproterone acetate and meningioma risk

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk … Continue reading

Posted in Antiandrogens, Endocrinology, Oncology, Progestogens | Tagged , , | Leave a comment

Three-year study examines trans women’s breast development from feminizing HRT

For trans women and transfeminine people who are considering or at the very beginning of feminizing hormone therapy, one of the most common points of concern – and uncertainty – is breast development. How soon will it start, how fast … Continue reading

Posted in Breast, Endocrinology, Outcomes of transition, Progestogens, Transfeminine | Tagged , , | Leave a comment

Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Disclaimer: I am not a medical professional and this is not medical advice. Cyproterone acetate (CPA) … Continue reading

Posted in Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine | Tagged , , , | 1 Comment